Innate Pharma (IPHA) Exchange Rate Effect (2019 - 2024)

Innate Pharma has reported Exchange Rate Effect for 5 years, with the latest figure at -$539640.7 in Q4 2024.

• For the quarter ending Q4 2024, Exchange Rate Effect changed N/A year-over-year to -$539640.7; the trailing twelve-month figure through Dec 2024 stood at -$1.7 million (changed N/A YoY), and the FY2025 full-year result was $1.3 million, up 335.55% from the prior year.
• Exchange Rate Effect for Q4 2024 stood at -$539640.7, down from -$436665.9 in the prior quarter.
• The five-year high for Exchange Rate Effect was -$14319.0 in Q2 2020, with the low at -$714928.0 in Q2 2022.
• Historically, Exchange Rate Effect has averaged -$412075.3 across 4 years, with a median of -$488153.3 in 2022.
• Annual changes were most pronounced in 2021 — Exchange Rate Effect sank 1397.04% — and 2022, when it increased 20.97%.
• Innate Pharma's Exchange Rate Effect stood at -$14319.0 in 2020, then plunged by 3758.78% to -$552538.0 in 2021, then increased by 20.97% to -$436665.9 in 2022, then dropped by 23.58% to -$539640.7 in 2024.
• The last three Exchange Rate Effect figures came in at -$539640.7 (Q4 2024), -$436665.9 (Q4 2022), and -$714928.0 (Q2 2022), per Business Quant data.